Sterile care develops the preventative and treatment related solutions to fight against the threat of serious infections.
Mission
To Provide effective solutions to reduce preventable complications associated with healthcare acquired infections, thereby improving the quality of care, aligning with global action plans on antimicrobial resistance and saving lives. SterileCare has a proprietary disinfectant solution that will significantly reduce the incidence of hospital acquired infections which are becoming increasingly more complicated to prevent and treat.
Hospital acquired infections are widely reported to cause unnecessary financial burden on the healthcare system, dramatically reduce the quality of healthcare and result in preventable losses of life. SterileCare’s products are focused on improving the quality of care to patients requiring medical treatment in Canadian healthcare facilities.
Founders
Karen Mueller
CEO
Karen is a biomedical executive leader, entrepreneur and visionary. She spent her career in life sciences, initially, as a registered nurse with a specialty in vascular access and then as a top National medical sales executive.
Karen has served on the Steering Committee for the Canadian Vascular Access and Infusion Therapy Guidelines and as well as a member of the Canadian Vascular Access Association (CVAA).
Karen is responsible for all global activity associated with SterileCare and represents the organization to the financial community, healthcare clinicians, government officials, shareholders and the public.
Dr. Chantal Lainesse
COO, CMO
Dr. Lainesse is part of a distinguished group of global leaders in Antimicrobial Stewardship and is a board-certified clinical pharmacologist and veterinarian. She leads SterileCare’s industry and research collaborations and advises on drug discovery, development, manufacturing and quality with Global pharmaceutical companies.
Dr. Lainesse’s goal is to pioneer biomedical technology that prevents infections and deaths resulting from complications from superbugs and biofilm. She has been a distinguished speaker and presenter at Canadian universities and conferences around the world. She is currently a member of several national and international scientific societies. Dr. Lainesse is also the author of several peer-reviewed scientific journal articles.
Awards
Women of Influence RBC Entrepreneur Nominee
Nominee RBC Women of the Year, 2020
First Women led Mission to South Korea
Trade Commissioner, Chosen representative, 2020
Southlake Regional Health Centre Innovation Award
Impact Award, 2017
Innovation Award
VentureLab Impact Award, 2016
VentureLab Impact Award
Innovation Award, 2016
Entrepreneur Award and CEO in Residence Program
Discovery Parks, 2012
Grants
MaRS, Embedded Executive Award
Chief Strategy Officer, 2018
Ontario Centre of Excellence (OCE)
Value Based Procurement Grant, 2015-2017
MaRS, Embedded Executive Award
Chief Financial Officer, 2016
MaRS, Embedded Executive Award
2012 & 2013